Hiscox Ltd Stock London S.E.
Equities
HSX
BMG4593F1124
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
05-08 | UBS raises Centrica to 'buy' from 'neutral | AN |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.98B 6.81B | Sales 2025 * | 4.27B 5.46B 7.47B | Capitalization | 3.9B 4.99B 6.83B |
---|---|---|---|---|---|
Net income 2024 * | 466M 596M 816M | Net income 2025 * | 500M 640M 875M | EV / Sales 2024 * | 1.13 x |
Net Debt 2024 * | 513M 656M 898M | Net Debt 2025 * | 513M 656M 898M | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
8.36
x | P/E ratio 2025 * |
7.68
x | Employees | - |
Yield 2024 * |
2.83% | Yield 2025 * |
3.13% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
1st Jan change | Capi. | |
---|---|---|
+53.73% | 67.31B | |
+12.03% | 50.37B | |
+16.66% | 43.1B | |
+34.21% | 37.28B | |
+70.45% | 31.9B | |
+12.79% | 29.9B | |
+27.14% | 25.65B | |
+1.87% | 22B | |
+42.39% | 20.21B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock